The safe enterocin DD14 is a leaderless two-peptide bacteriocin with anti-Clostridium perfringens activity

International Journal of Antimicrobial Agents

Volumn 49, Issue 3, 2017, Pages 282-289

  Caly, Delphine L ^a   Chevalier, Mickaël ^a   Flahaut, Christophe ^a   Cudennec, Benoit ^a   Al Atya, Ahmed Khassaf ^a   Chataigné, Gabrielle ^a   D'Inca, Romain ^b   Auclair, Eric ^b   Drider, Djamel ^a  

^a Cité scientifique   (France)

^b Lesaffre International   (France)

Author keywords

Bacteriocin; Clostridium perfringens; Cytotoxicity; Enterococcus faecalis

Indexed keywords

AMOXICILLIN; BACTERIOCIN; DD14A PROTEIN; DD14B PROTEIN; ENTEROCIN DD14; MR10A PROTEIN; MR10B PROTEIN; UNCLASSIFIED DRUG; ANTIINFECTIVE AGENT; BRIDGED COMPOUND; ENTEROCIN; PEPTIDE;

AMINO ACID SEQUENCE; ANTIBACTERIAL ACTIVITY; ARTICLE; BACTERIAL GENE; BACTERIAL STRAIN; CELL LINE; CLOSTRIDIUM PERFRINGENS; CONTROLLED STUDY; DRUG CLASSIFICATION; DRUG CYTOTOXICITY; ENTEROCIN GENE; ENTEROCOCCUS FAECALIS; GENE AMPLIFICATION; GENOTYPE; IPEC-1 CELL LINE; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MINIMUM INHIBITORY CONCENTRATION; MOLECULAR SIZE; NONHUMAN; PROTEIN PURIFICATION; PROTEIN STRUCTURE; ANIMAL; CELL SURVIVAL; CHEMISTRY; DNA SEQUENCE; DRUG EFFECTS; EPITHELIUM CELL; ISOLATION AND PURIFICATION; METABOLISM; MICROBIAL SENSITIVITY TEST; MOLECULAR WEIGHT; PHYSIOLOGY; PIG; SEQUENCE HOMOLOGY;

ANIMALS; ANTI-BACTERIAL AGENTS; BRIDGED-RING COMPOUNDS; CELL LINE; CELL SURVIVAL; CLOSTRIDIUM PERFRINGENS; ENTEROCOCCUS FAECALIS; EPITHELIAL CELLS; MICROBIAL SENSITIVITY TESTS; MOLECULAR WEIGHT; PEPTIDES; SEQUENCE ANALYSIS, DNA; SEQUENCE HOMOLOGY; SWINE;

EID: 85011628978     PISSN: 09248579     EISSN: 18727913     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2016.11.016     Document Type: Article

References (40)

1. [1] Kaldhusdal, M., Løvland, A., The economical impact of Clostridium perfringens is greater than anticipated. World Poult 16 (2000), 50–51.
2. [2] Lee, K.W., Lillehoj, H.S., Jeong, W., Jeoung, H.Y., An, D.J., Avian necrotic enteritis: experimental models, host immunity, pathogenesis, risk factors, and vaccine development. Poult Sci 90 (2011), 1381–1390.
3. [3] Popoff, M.R., Clostridium. Drider, D., Salvat, G., (eds.) Sécurité Sanit. des Aliment. Epidémiologie lutte contre les Contam. zoonotiques, 2013, Economica, Paris, France, 165–189.
4. [4] Songer, J.G., Clostridial enteric diseases of domestic animals. Clin Microbiol Rev 9 (1996), 216–234.
5. [5] Parish, W.E., Necrotic enteritis in the fowl. II. Examination of the causal Clostridium welchii. J Comp Pathol 71 (1961), 394–404.
6. [6] Cooper, K.K., Songer, J.G., Necrotic enteritis in chickens: a paradigm of enteric infection by Clostridium perfringens type A. Anaerobe 15 (2009), 55–60.
7. [7] Keyburn, A.L., Boyce, J.D., Vaz, P., Bannam, T.L., Ford, M.E., Parker, D., et al. NetB, a new toxin that is associated with avian necrotic enteritis caused by Clostridium perfringens. PLoS Pathog, 4, 2008 e26.
8. [8] Baba, E., Wakeshima, H., Fukui, K., Fukata, T., Arakawa, A., Adhesion of bacteria to the cecal mucosal surface of conventional and germ-free chickens infected with Eimeria tenella. Am J Vet Res 53 (1992), 194–197.
9. [9] Casewell, M., Friis, C., Marco, E., McMullin, P., Phillips, I., The European ban on growth-promoting antibiotics and emerging consequences for human and animal health. J Antimicrob Chemother 52 (2003), 159–161.
10. [10] Engberg, R.M., Hedemann, M.S., Steenfeldt, S., Jensen, B.B., Influence of whole wheat and xylanase on broiler performance and microbial composition and activity in the digestive tract. Poult Sci 83 (2004), 925–938.
11. [11] Liu, D., Guo, Y., Wang, Z., Yuan, J., Exogenous lysozyme influences Clostridium perfringens colonization and intestinal barrier function in broiler chickens. Avian Pathol 39 (2010), 17–24.
12. [12] Timbermont, L., Lanckriet, A., Dewulf, J., Nollet, N., Schwarzer, K., Haesebrouck, F., et al. Control of Clostridium perfringens-induced necrotic enteritis in broilers by target-released butyric acid, fatty acids and essential oils. Avian Pathol 39 (2010), 117–121.
13. [13] Engberg, R.M., Grevsen, K., Ivarsen, E., Frette, X., Christensen, L.P., Hojberg, O., et al. The effect of Artemisia annua on broiler performance, on intestinal microbiota and on the course of a Clostridium perfringens infection applying a necrotic enteritis disease model. Avian Pathol 41 (2012), 369–376.
14. [14] Caly, D.L., D'Inca, R., Auclair, E., Drider, D., Alternatives to antibiotics to prevent necrotic enteritis in broiler chickens: a microbiologist's perspective. Front Microbiol 6 (2015), 1–21.
15. [15] Shin, M.S., Han, S.K., Ji, A.R., Kim, K.S., Lee, W.K., Isolation and characterization of bacteriocin-producing bacteria from the gastrointestinal tract of broiler chickens for probiotic use. J Appl Microbiol 105 (2008), 2203–2212.
16. [16] Chen, Y.S., Yanagida, F., Srionnual, S., Characteristics of bacteriocin-like inhibitory substances from dochi-isolated Enterococcus faecium D081821 and D081833. Lett Appl Microbiol 44 (2007), 320–325.
17. [17] Stark, J.M., Antibiotic activity of haemolytic enterococci. Lancet 1 (1960), 733–734.
18. [18] Bottone, E., Allerhand, J., Pisano, M.A., Effects of a bacteriocin produced by Streptococcus faecalis var. zymogenes (E1) on susceptible microorganisms. Antonie Van Leeuwenhoek 40 (1974), 385–392.
19. [19] Cao, G.T., Zeng, X.F., Chen, A.G., Zhou, L., Zhang, L., Xiao, Y.P., et al. Effects of a probiotic, Enterococcus faecium, on growth performance, intestinal morphology, immune response, and cecal microflora in broiler chickens challenged with Escherichia coli K88. Poult Sci 92 (2013), 2949–2955.
20. [20] Fukata, T., Hadate, Y., Baba, E., Arakawa, A., Influence of bacteria on Clostridium perfringens infections in young chickens. Avian Dis 35 (2015), 224–227.
21. [21] Joosten, H.M., Nunez, M., Devreese, B., Van Beeumen, J., Marugg, J.D., Purification and characterization of enterocin 4, a bacteriocin produced by Enterococcus faecalis INIA 4. Appl Environ Microbiol 62 (1996), 4220–4223.
22. [22] Martinez-Bueno, M., Maqueda, M., Galvez, A., Samyn, B., Van Beeumen, J., Coyette, J., et al. Determination of the gene sequence and the molecular structure of the enterococcal peptide antibiotic AS-48. J Bacteriol 176 (1994), 6334–6339.
23. [23] Cintas, L.M., Casaus, P., Holo, H., Hernandez, P.E., Nes, I.F., Havarstein, L.S., Enterocins L50A and L50B, two novel bacteriocins from Enterococcus faecium L50, are related to staphylococcal hemolysins. J Bacteriol 180 (1998), 1988–1994.
24. [24] Liu, X., Vederas, J.C., Whittal, R.M., Zheng, J., Stiles, M.E., Carlson, D., et al. Identification of an N-terminal formylated, two-peptide bacteriocin from Enterococcus faecalis 710C. J Agric Food Chem 59 (2011), 5602–5608.
25. [25] Martín-Platero, A.M., Valdivia, E., Ruíz-Rodríguez, M., Soler, J.J., Martín-Vivaldi, M., Maqueda, M., et al. Characterization of antimicrobial substances produced by Enterococcus faecalis MRR 10-3, isolated from the uropygial gland of the hoopoe (Upupa epops). Appl Environ Microbiol 72 (2006), 4245–4249.
26. [26] Al Atya, A.K., Drider-Hadiouche, K., Ravallec, R., Silvain, A., Vachee, A., Drider, D., Probiotic potential of Enterococcus faecalis strains isolated from meconium. Front Microbiol, 6, 2015, 227.
27. [27] Gale, E.F., Brown, G.L., MacIntosh, F.C., White, B., Production of amines by bacteria: the decarboxylation of amino-acids by organisms of the groups Clostridium and Proteus with an addendum by G. L. Brown, F. C. Macintosh and P. Bruce White. Biochem J 35 (1941), 66–80.
28. [28] Hobbs, B.C., Smith, M.E., Oakley, C.L., Warrack, G.H., Cruickshank, J.C., Clostridium welchii food poisoning. J Hyg (Lond) 51 (1953), 75–101.
29. [29] Galvez, A., Maqueda, M., Valdivia, E., Quesada, A., Montoya, E., Characterization and partial purification of a broad spectrum antibiotic AS-48 produced by Streptococcus faecalis. Can J Microbiol 32 (1986), 765–771.
30. [30] Wiegand, I., Hilpert, K., Hancock, R.E., Agar and broth dilution methods to determine the minimal inhibitory concentration (MIC) of antimicrobial substances. Nat Protoc 3 (2008), 163–175.
31. [31] Hall, T.A., BioEdit: a user-friendly biological sequence alignment editor and analysis program for Windows 95/98/NT. Nucleic Acids Symp Ser 41 (1999), 95–98.
32. [32] Al Kassaa, I., Hamze, M., Hober, D., Chihib, N.E., Drider, D., Identification of vaginal lactobacilli with potential probiotic properties isolated from women in North Lebanon. Microb Ecol 67 (2014), 722–734.
33. [33] Abriouel, H., Valdivia, E., Martínez-Bueno, M., Maqueda, M., Gálvez, A., A simple method for semi-preparative-scale production and recovery of enterocin AS-48 derived from Enterococcus faecalis subsp. liquefaciens A-48-32. J Microbiol Methods 55 (2003), 599–605.
34. [34] Lohans, C.T., Towle, K.M., Miskolzie, M., McKay, R.T., van Belkum, M.J., McMullen, L.M., et al. Solution structures of the linear leaderless bacteriocins enterocin 7A and 7B resemble carnocyclin A, a circular antimicrobial peptide. Biochemistry 52 (2013), 3987–3994.
35. [35] Maher, S., McClean, S., Investigation of the cytotoxicity of eukaryotic and prokaryotic antimicrobial peptides in intestinal epithelial cells in vitro. Biochem Pharmacol 71 (2006), 1289–1298.
36. [36] Belguesmia, Y., Madi, A., Sperandio, D., Merieau, A., Feuilloley, M., Prévost, H., et al. Growing insights into the safety of bacteriocins: the case of enterocin S37. Res Microbiol 162 (2011), 159–163.
37. [37] Aasen, I.M., Møretrø, T., Katla, T., Axelsson, L., Storrø, I., Influence of complex nutrients, temperature and pH on bacteriocin production by Lactobacillus sakei CCUG 42687. Appl Microbiol Biotechnol 53 (2000), 159–166.
38. [38] Basanta, A., Gomez-Sala, B., Sanchez, J., Diep, D.B., Herranz, C., Hernandez, P.E., et al. Use of the yeast Pichia pastoris as an expression host for secretion of enterocin L50, a leaderless two-peptide (L50A and L50B) bacteriocin from Enterococcus faecium L50. Appl Environ Microbiol 76 (2010), 3314–3324.
39. [39] Cintas, L.M., Casaus, P., Herranz, C., Hâvarstein, L.S., Holo, H., Hernández, P.E., et al. Biochemical and genetic evidence that Enterococcus faecium L50 produces enterocins L50A and L50B, the sec-dependent enterocin P, and a novel bacteriocin secreted without an N-terminal extension termed enterocin Q. J Bacteriol 182 (2000), 6806–6814.
40. [40] Al Atya, A.K., Abriouel, H., Kempf, I., Jouy, E., Auclair, E., Vachée, A., et al. Effects of colistin and bacteriocins combinations on the in vitro growth of Escherichia coli strains from swine origin. Probiotics Antimicrob Proteins 8 (2016), 183–190.